Detalhe da pesquisa
1.
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation.
Acta Haematol
; 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827141
2.
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
Front Immunol
; 11: 1068, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547559
3.
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Front Immunol
; 10: 1997, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31507601